Description
This Treatment Improvement Protocol (TIP) reviews what is currently known about treating the medical, psychiatric, and SUD-related problems associated with the use of cocaine and MA and the misuse of prescribed stimulants (such as those for the treatment of attention deficit hyperactivity disorder [ADHD]). The scientifically based information in this TIP is presented in a manner that makes it accessible and relevant to behavioral health service clinicians and other frontline SUD treatment providers, including healthcare service providers (e.g., in primary care settings, in emergency departments). The TIP offers recommendations on identification, treatment approaches, strategies for planning and initiating treatment, recommendations on how to maximize treatment engagement and retention, and strategies for initiating and maintaining abstinence. Also included are recommendations for the medical management of people
who use stimulants and recommendations regarding special populations and settings.
7/2020 At Health requested and received permission to use SAMHSA publications (with proper citation) in their entirety for CE courses at athealth.com
This CE program is designated as beginner.
Target audience: Psychologists, mental health counselors, marriage and family therapists, social workers, addiction counselors, nurses
Format: Reading-based asynchronous distance
Course Content Categories: Substance Abuse; Clinical; Treatment and Diagnosis; Clinical Intake and Screening; Clinical Assessment; Treatment plan;
Published by SAMHSA 2021. Published by At Health 4/22
NAADAC Participants: Participants earning NAADAC approved CE credits for online courses will be limited to eight (8) hours of credit within a twenty-four (24) hour period.
Conflict of Interest: None to disclose
Author Bio
SAMHSA. U.S. Department of Health and Human Services.
Substance Abuse and Mental Health Services Administration. 2021
Dr. Miriam E. Delphin-Rittmon was formerly the Assistant Secretary for Mental Health and Substance Use in the U.S. Department of Health and Human Services and the Administrator of the Substance Abuse and Mental Health Services Administration (SAMHSA). As the Assistant Secretary, Dr. Delphin-Rittmon was charged with addressing the behavioral health of the nation and improving the lives of individuals living with mental and substance use disorders and their families.
Dr. Delphin-Rittmon led SAMHSA in standing up the 988 Suicide and Crisis Lifeline, which offers free 24/7 crisis support, and in addressing overdose SAMHSA increased nationwide naloxone distribution by 33%, contributing to a 15% reduction in overdose deaths – the first decrease we have seen in over five years.
She previously served as Commissioner of the Connecticut Department of Mental Health and Addiction Services (DMHAS) from 2015 to 2021. Prior to this role, she served as Deputy Commissioner, Senior Policy Advisor, and Director of the Office of Multicultural Healthcare Equity at DMHAS. In her role as Commissioner, Dr. Delphin-Rittmon was committed to promoting recovery oriented, integrated, and culturally responsive services and systems that foster dignity, respect, and meaningful community inclusion.
In addition, Dr. Delphin-Rittmon served on the faculty at Yale University in the Department of Psychiatry for 20 years, most recently as Adjunct Associate Professor and previously as Assistant Professor. While at Yale, Dr. Delphin-Rittmon also served as the Director of Cultural Competence and Health Disparities Research and Consultation with the Yale University Program for Recovery and Community Health.
In May 2014, Dr. Delphin-Rittmon completed a two-year White House appointment working as a Senior Advisor to the Administrator of SAMHSA with the U.S. Department of Health and Human Services. While at SAMHSA, she worked on a broad range of policy initiatives addressing behavioral health equity, workforce development, and healthcare reform.
Dr. Delphin-Rittmon has earned numerous awards for her work including a 2025 Presidential Citation from the American Psychological Association, the 2024 National Leadership Award from the Community Anti-Drug Coalitions of America, the 2024 College of Health and Human Sciences Distinguished Alumni Award from Purdue University and the 2024 Visionary Leadership Award from the American Psychiatric Association.
CE Approvals
At Health, LLC is approved by the American Psychological Association to sponsor continuing education for psychologists. At Health, LLC maintains responsibility for this program and its content.
At Health, LLC has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6949. Programs that do not qualify for NBCC credit are clearly identified. At Health, LLC is solely responsible for all aspects of the programs.
Athealth.com is approved as a continuing education provider by the National Association of Alcoholism and Drug Abuse Counselors (NAADAC) Provider #148460.
At Health, LLC, Provider #1707, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. At Health, LLC, maintains responsibility for this course. ACE provider approval period: 5/3/2023-5/3/2026.
It is At Health's understanding that these programs meet the criteria of an approved continuing education program for social work in Arkansas. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.
It is At Health's understanding that these programs meet the criteria of an approved continuing education program for social workers, professional counselors, marriage and family therapists, master's level psychologists, licensed clinical psychotherapists, and alcohol and other drug abuse counselors in Kansas. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.
It is At Health's understanding that these programs meet the criteria of an approved continuing education program for mental health practice and for social work in Nebraska. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.
It is At Health's understanding that these programs meet the criteria of an approved continuing education program for psychologists, pastoral psychotherapists, clinical social workers, clinical mental health counselors, marriage and family therapists, and alcohol and drug abuse counselors in New Hampshire. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.
It is At Health's understanding that these programs meet the criteria of an approved continuing education program for social workers, professional counselors, marital and family therapists, and clinical pastoral therapists in Tennessee. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.
Other jurisdictions may accept trainings offered by At Health, LLC for your continuing education requirements. Restrictions may apply. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.”
.
Page last modified or reviewed by athealth.com on May 22, 2025.
Learning Objectives
Based on the content of this course, I can:
- Explain the neurobiology of stimulant use disorders
- Summarize the empirical evidence supporting the use of Contingency Management (CM), Cognitive-behavioral Therapy (CBT), Community Reinforcement, and Motivational Interviewing
- List signs, symptoms, and harmful effects of stimulant use and stimulant use disorders and how to best manage common complications
- Tell the factors that make treatment engagement more likely
- Discuss why numerous populations may be at increased risk for developing a stimulant use disorder or for experiencing negative outcomes
- Give examples of resources available for professionals in the substance use disorder (SUD) treatment and recovery services field
- Describe the complexities of diagnosing stimulant use disorder in an individual with mental illness
Jill (verified owner) –
Crystal (verified owner) –
Andy –
Great!
Fred (verified owner) –
Caitlin (verified owner) –
Linda (verified owner) –
Eddie (verified owner) –
Nicole (verified owner) –
Theresa (verified owner) –
Kevin (verified owner) –
Ivan (verified owner) –
Tommy (verified owner) –
Nicholas (verified owner) –
Tara (verified owner) –
Alexander (verified owner) –
Devin (verified owner) –
Saba (verified owner) –
Lisa (verified owner) –
Trevor (verified owner) –
Amanda (verified owner) –